Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › IN › COLUMBIA CITY › WHITLEY MEMORIAL HOSPITAL, INC.

WHITLEY MEMORIAL HOSPITAL, INC.

NPI: 1205844495 · COLUMBIA CITY, IN 46725 · Institutional Pharmacy · NPI assigned 08/03/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official RISSER, STANTON controls 20+ related entities in our dataset. Read more

$9.54M
Total Medicaid Paid
162,052
Total Claims
134,839
Beneficiaries
85
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialRISSER, STANTON (ACFO)
Parent OrganizationWHITLEY MEMORIAL HOSPITAL, INC.
NPI Enumeration Date08/03/2006

Related Entities

Other providers sharing the same authorized official: RISSER, STANTON

ProviderCityStateTotal Paid
PARKVIEW HOSPITAL, INC. FORT WAYNE IN $93.04M
PARK CENTER, INC. FORT WAYNE IN $49.95M
PARK CENTER INC FORT WAYNE IN $26.68M
MEMORIAL HOSPITAL LOGANSPORT IN $15.39M
PARKVIEW LOGANSPORT HOSPITAL, INC. LOGANSPORT IN $9.76M
COMMUNITY HOSPITAL OF NOBLE COUNTY, INC. KENDALLVILLE IN $8.47M
COMMUNITY HOSPITALS AND WELLNESS CENTERS BRYAN OH $7.29M
HUNTINGTON MEMORIAL HOSPITAL, INC. HUNTINGTON IN $6.49M
PARKVIEW WABASH HOSPITAL, INC. WABASH IN $6.40M
PARKVIEW HOSPITAL, INC. FORT WAYNE IN $3.77M
PARKVIEW WABASH HOSPITAL, INC. WABASH IN $3.44M
HUNTINGTON MEMORIAL HOSPITAL, INC. HUNTINGTON IN $2.66M
COMMUNITY HOSPITAL OF NOBLE COUNTY, INC. KENDALLVILLE IN $1.96M
COMMUNITY HOSPITAL OF LAGRANGE COUNTY INC LAGRANGE IN $1.62M
WHITLEY MEMORIAL HOSPITAL, INC. COLUMBIA CITY IN $1.33M
PARKVIEW WABASH HOSPITAL, INC. NORTH MANCHESTER IN $374K
ORTHOPAEDIC HOSPITAL AT PARKVIEW NORTH, LLC FORT WAYNE IN $221K
PARKVIEW LOGANSPORT HOSPITAL, INC. LOGANSPORT IN $49K
PARKVIEW LOGANSPORT HOSPITAL, INC. LOGANSPORT IN $34K
PARKVIEW ORTHO CENTER, LLC FORT WAYNE IN $16K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 26,620 $595K
2019 21,111 $899K
2020 16,315 $937K
2021 23,198 $1.51M
2022 32,665 $2.46M
2023 29,928 $2.10M
2024 12,215 $1.05M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 33,639 29,551 $5.75M
99284 Emergency department visit for the evaluation and management, high severity 12,548 10,372 $1.88M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 5,170 4,109 $328K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 3,606 3,134 $236K
71045 Radiologic examination, chest; single view 1,782 1,393 $231K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,140 1,058 $143K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 572 475 $141K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3,993 3,373 $113K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 21,870 18,107 $94K
80048 Basic metabolic panel (calcium, ionized) 19,279 15,283 $86K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,240 1,049 $85K
71046 Radiologic examination, chest; 2 views 708 629 $66K
36415 Collection of venous blood by venipuncture 22,462 18,406 $45K
74177 Computed tomography, abdomen and pelvis; with contrast material 99 74 $34K
80076 5,860 4,782 $26K
J7030 Infusion, normal saline solution , 1000 cc 1,079 862 $22K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 275 74 $19K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 635 580 $17K
99217 56 43 $15K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 213 193 $14K
80053 Comprehensive metabolic panel 2,097 1,863 $13K
84484 1,925 1,448 $13K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 118 114 $12K
99238 Hospital discharge day management, 30 minutes or less 28 24 $11K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 311 248 $11K
81001 5,638 4,711 $10K
70450 Computed tomography, head or brain; without contrast material 112 85 $8K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 387 347 $8K
96361 Intravenous infusion, hydration; each additional hour 278 216 $8K
99219 19 15 $8K
80061 Lipid panel 870 793 $8K
99221 15 13 $8K
83735 2,230 1,778 $7K
83690 2,496 2,052 $7K
84443 Thyroid stimulating hormone (TSH) 617 567 $7K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring 49 41 $6K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 148 134 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 401 296 $4K
85027 1,191 854 $4K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 216 203 $4K
87086 Culture, bacterial; quantitative colony count, urine 1,025 839 $4K
87634 61 54 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 543 480 $4K
83036 Hemoglobin; glycosylated (A1C) 394 357 $3K
81025 438 374 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 199 181 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 39 37 $2K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 30 26 $1K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 44 38 $1K
87081 249 228 $973.41
84703 198 176 $843.94
J7120 Ringers lactate infusion, up to 1000 cc 19 13 $810.81
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 14 13 $456.17
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 14 13 $456.17
96375 Therapeutic injection; each additional sequential IV push 141 118 $442.26
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 18 15 $442.26
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 16 13 $388.68
81003 280 237 $317.89
82553 91 82 $301.31
83605 52 40 $288.62
82550 96 83 $276.04
74022 30 26 $253.28
87480 13 12 $252.64
87510 13 12 $252.64
87660 13 12 $252.64
85379 33 26 $232.06
82043 53 41 $159.89
80047 16 13 $114.62
83550 14 14 $110.76
82962 29 12 $95.39
82077 14 12 $83.75
83540 14 14 $82.02
87040 21 12 $77.91
87077 30 25 $66.54
86592 14 14 $53.82
85610 66 55 $27.28
85652 17 12 $23.58
J2405 Injection, ondansetron hydrochloride, per 1 mg 270 213 $4.90
93041 16 13 $4.00
J1885 Injection, ketorolac tromethamine, per 15 mg 408 350 $0.00
A0428 Ambulance service, basic life support, non-emergency transport, (bls) 85 71 $0.00
A0425 Ground mileage, per statute mile 1,188 871 $0.00
A0429 Ambulance service, basic life support, emergency transport (bls-emergency) 217 163 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 44 36 $0.00
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg 101 44 $0.00